These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
490 related items for PubMed ID: 16080521
1. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H. Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521 [Abstract] [Full Text] [Related]
2. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma. Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T. J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354 [Abstract] [Full Text] [Related]
3. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma. Nakashima S, Natsugoe S, Matsumoto M, Kijima F, Takebayashi Y, Okumura H, Shimada M, Nakano S, Kusano C, Baba M, Takao S, Aikou T. Anticancer Res; 2000 Jul 01; 20(3B):1933-7. PubMed ID: 10928129 [Abstract] [Full Text] [Related]
4. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. Sarbia M, Stahl M, Fink U, Willers R, Seeber S, Gabbert HE. Clin Cancer Res; 1998 Dec 01; 4(12):2991-7. PubMed ID: 9865911 [Abstract] [Full Text] [Related]
5. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck. Fouret P, Temam S, Charlotte F, Lacau-St-Guily J. Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767 [Abstract] [Full Text] [Related]
6. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y. Ann Surg Oncol; 2010 Mar 02; 17(3):804-11. PubMed ID: 19885698 [Abstract] [Full Text] [Related]
7. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus. Heeren PA, Kloppenberg FW, Hollema H, Mulder NH, Nap RE, Plukker JT. Anticancer Res; 2004 Mar 02; 24(4):2579-83. PubMed ID: 15330218 [Abstract] [Full Text] [Related]
8. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. Shimoyama S, Konishi T, Kawahara M, Aoki F, Harada N, Shimizu S, Murakami T, Kaminishi M. Hepatogastroenterology; 1998 Mar 02; 45(23):1497-504. PubMed ID: 9840093 [Abstract] [Full Text] [Related]
9. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Moreira LF, Naomoto Y, Hamada M, Kamikawa Y, Orita K. Anticancer Res; 1995 Mar 02; 15(2):639-44. PubMed ID: 7539243 [Abstract] [Full Text] [Related]
10. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. Laryngoscope; 2002 Apr 02; 112(4):638-44. PubMed ID: 12150516 [Abstract] [Full Text] [Related]
12. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F. Clin Cancer Res; 1995 Nov 02; 1(11):1375-83. PubMed ID: 9815934 [Abstract] [Full Text] [Related]
13. [Expression and significance of heat shock proteins in esophageal squamous cell carcinoma]. Chen JH, Chen LM, Xu LY, Wu MY, Shen ZY. Zhonghua Zhong Liu Za Zhi; 2006 Oct 02; 28(10):758-61. PubMed ID: 17366788 [Abstract] [Full Text] [Related]
14. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma. Samejima R, Kitajima Y, Yunotani S, Miyazaki K. Anticancer Res; 1999 Oct 02; 19(6C):5515-21. PubMed ID: 10697609 [Abstract] [Full Text] [Related]
15. Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy. Koukourakis MI, Corti L, Skarlatos J, Giatromanolaki A, Krammer B, Blandamura S, Piazza M, Verwanger T, Schnitzhofer G, Kostandelos J, Beroukas K. Anticancer Res; 2001 Oct 02; 21(1B):663-8. PubMed ID: 11299823 [Abstract] [Full Text] [Related]
16. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y. Clin Cancer Res; 1999 Apr 02; 5(4):801-6. PubMed ID: 10213215 [Abstract] [Full Text] [Related]
17. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Allal AS, Waelchli L, Bründler MA. Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153 [Abstract] [Full Text] [Related]
18. Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer. Farkas R, Pozsgai E, Bellyei S, Cseke L, Szigeti A, Vereczkei A, Marton S, Mangel L, Horvath OP, Papp A. Anticancer Res; 2011 May 15; 31(5):1769-75. PubMed ID: 21617238 [Abstract] [Full Text] [Related]
19. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M, Takiuchi H, Kawabe S, Ohta S, Kii T, Kuwakado S, Katsu K. Jpn J Clin Oncol; 2007 Sep 15; 37(9):652-7. PubMed ID: 17940077 [Abstract] [Full Text] [Related]
20. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53]. Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J. Gastroenterol Clin Biol; 1995 May 15; 19(5):465-74. PubMed ID: 7589997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]